Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LLY vs MRNA✓SelectedUSD · MRNALLY vs MRNA performance historyLatest closeAs of-0.30%11/20
Stock and ETF performance explorer

LLY vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+130.0%
MRNA return
+153.9%
Excess return
-23.9%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.3%-2.2%+1.9%-0.2%
7D-6.7%-12.7%+6.0%-6.2%
30D+6.1%-20.7%+26.8%+7.0%
3M+8.4%+46.3%-37.9%+6.3%
6M+32.6%+305.2%-272.7%+19.7%
YTD+26.1%+561.2%-535.1%+9.4%
1Y+29.9%+772.1%-742.2%+10.3%
3Y+130.0%+147.0%-17.0%+98.8%
All+130.0%+153.9%-23.9%+98.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling